Tecogen appoints Dr. John M. Albertine to Board of Directors and Audit Committee

TECOGEN INC.

Dr. Albertine appointed as director and Audit Committee member effective November 28, 2022.
Appointment fills a vacancy on Tecogen's Board of Directors.
Announced on December 7, 2022; written consent dated November 28, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. John M. Albertine

director

TGEN · TECOGEN INC.

Effective: 2022-11-28
Filed: December 8, 2022, 6:59 PM ET

On December 7, 2022, Tecogen Inc. (the “Company”) announced that Dr. John M. Albertine has been appointed as a director of the Company and a member of the Company’s Audit Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. John M. Albertine was appointed as director at TECOGEN INC..

Action: appointed
Role: director

Exact text from the filing

On December 7, 2022, Tecogen Inc. (the “Company”) announced that Dr. John M. Albertine has been appointed as a director of the Company and a member of the Company’s Audit Committee.

View on SEC.gov

TECOGEN INC. filing history →

Source: SEC EDGAR

accession 0001537435-22-000134

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.